These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10897917)

  • 1. [High dosage corticosteroids: in multiple sclerosis pulse therapy is of value].
    Gold R
    MMW Fortschr Med; 1999 Jun; 141(25):76-7. PubMed ID: 10897917
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic strategies for multiple sclerosis--update 2008].
    Kanter vI; Mäurer M
    MMW Fortschr Med; 2008 Jun; 150(23):42-5. PubMed ID: 18575371
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic indications targeting etiology. (With the exception of primary progressive forms)].
    Brassat D
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1014-28. PubMed ID: 11787332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid treatment for relapses in multiple sclerosis - the evidence urges shared decision-making.
    Köpke S; Heesen C; Kasper J; Mühlhauser I
    Acta Neurol Scand; 2004 Jul; 110(1):1-5. PubMed ID: 15180800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic, steroid-induced, multifocal diaphyseal osteonecrosis in a patient with multiple sclerosis.
    Sinclair V; Shepard G
    Mult Scler; 2010 Mar; 16(3):370-2. PubMed ID: 20086027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress of therapy in patients with multiple sclerosis].
    Kümpfel T; Havla J; Hohlfeld R
    MMW Fortschr Med; 2010 Mar; 152(9):42-4. PubMed ID: 20384096
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
    Havrdova E; Zivadinov R; Krasensky J; Dwyer MG; Novakova I; Dolezal O; Ticha V; Dusek L; Houzvickova E; Cox JL; Bergsland N; Hussein S; Svobodnik A; Seidl Z; Vaneckova M; Horakova D
    Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids].
    Voltz R; Hohlfeld R
    Nervenarzt; 1992 Dec; 63(12):773-5. PubMed ID: 1494395
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cortisol suppression in corticoid therapy. Comments on the contribution by R. Voltz and R. Hohlfeld. Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids].
    Haupts M; Schlüter T; Gehlen W
    Nervenarzt; 1993 Jun; 64(6):413. PubMed ID: 8332236
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Engel WK
    Neurology; 2009 Sep; 73(13):1077; author reply 1077-8. PubMed ID: 19786702
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrent atrial fibrillation after pulse corticosteroid treatment for a relapse of multiple sclerosis.
    Pavičić T; Ruška B; Adamec I; Habek M
    Mult Scler Relat Disord; 2019 Jul; 32():30-32. PubMed ID: 31029055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial.
    Köpke S; Kasper J; Mühlhauser I; Nübling M; Heesen C
    Mult Scler; 2009 Jan; 15(1):96-104. PubMed ID: 18845657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of ECT and anesthesia in the setting of multiple sclerosis.
    Fitzsimons MG; Welch CA; Haspel KL; Gorman JM
    J Psychiatr Pract; 2007 May; 13(3):195-8. PubMed ID: 17522564
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of remitting forms of multiple sclerosis].
    Lubetzki C
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):996-1000. PubMed ID: 11787366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism as a manifestation of multiple sclerosis.
    Folgar S; Gatto EM; Raina G; Micheli F
    Mov Disord; 2003 Jan; 18(1):108-10. PubMed ID: 12518309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cortisone pulse therapy in dermatology: controlled use promises high rate of success].
    Reinhold U
    MMW Fortschr Med; 1999 Jun; 141(25):78-9. PubMed ID: 10897918
    [No Abstract]   [Full Text] [Related]  

  • 17. [Corticosteroid therapy in multiple sclerosis. Comment on the letter by M. Haupts et al].
    Hohlfeld R; Engelhardt D
    Nervenarzt; 1994 Feb; 65(2):148. PubMed ID: 8164771
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Khan OA; Tselis A; Boster A
    Neurology; 2009 Jun; 72(24):2134; author reply 2134-5. PubMed ID: 19528523
    [No Abstract]   [Full Text] [Related]  

  • 19. [General practitioners' approach to relapsing multiple sclerosis].
    Mackowiak A; Jamart V; Donze C; Hautecoeur P;
    Rev Neurol (Paris); 2003 Feb; 159(2):196-8. PubMed ID: 12660572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment.
    Flachenecker P; Meissner H
    Mult Scler; 2008 Mar; 14(2):274-7. PubMed ID: 18337428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.